OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Antineoplastic indole-containing compounds with potential VEGFR inhibitory properties
Dalia R. Aboshouk, Mohamed A. Youssef, Mohamed S. Bekheit, et al.
RSC Advances (2024) Vol. 14, Iss. 9, pp. 5690-5728
Open Access | Times Cited: 8
Dalia R. Aboshouk, Mohamed A. Youssef, Mohamed S. Bekheit, et al.
RSC Advances (2024) Vol. 14, Iss. 9, pp. 5690-5728
Open Access | Times Cited: 8
Showing 8 citing articles:
The Past and Future of Angiogenesis as a Target for Cancer Therapy and Prevention
Adriana Albini, Douglas M. Noonan, Paola Corradino, et al.
Cancer Prevention Research (2024) Vol. 17, Iss. 7, pp. 289-303
Closed Access | Times Cited: 6
Adriana Albini, Douglas M. Noonan, Paola Corradino, et al.
Cancer Prevention Research (2024) Vol. 17, Iss. 7, pp. 289-303
Closed Access | Times Cited: 6
The Therapeutic Potential of Spirooxindoles in Cancer: A Focus on p53–MDM2 Modulation
Adel S. Girgis, Yujun Zhao, Angel Nkosi, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 274-274
Open Access
Adel S. Girgis, Yujun Zhao, Angel Nkosi, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 274-274
Open Access
Indole Compounds in Oncology: Therapeutic Potential and Mechanistic Insights
S. M. E. HASSAN, Alyaa Farid, Siva S. Panda, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 922-922
Open Access | Times Cited: 3
S. M. E. HASSAN, Alyaa Farid, Siva S. Panda, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 922-922
Open Access | Times Cited: 3
Synthesis and anti-tumor activity of new benzofuran-based chalcone derivatives as potent VEGFR-2 inhibitors
Chunfei Zhang, Yixin Liu, Xiao Zhang, et al.
RSC Medicinal Chemistry (2024)
Closed Access | Times Cited: 1
Chunfei Zhang, Yixin Liu, Xiao Zhang, et al.
RSC Medicinal Chemistry (2024)
Closed Access | Times Cited: 1
Development of 3-indolyl substituted phenyl pyrazolo-carboxamide hybrids as potential type II VEGFR-2 inhibitors and in vitro cytotoxicity studies
Durgesh Gurukkala Valapil, Geetanjali Devabattula, Aman Singh Barahdia, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 117, pp. 130070-130070
Closed Access | Times Cited: 1
Durgesh Gurukkala Valapil, Geetanjali Devabattula, Aman Singh Barahdia, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 117, pp. 130070-130070
Closed Access | Times Cited: 1
Development of 3-Indolyl Substituted Phenyl Pyrazolo-Carboxamide Hybrids as Potential Type Ii Vegfr-2 Inhibitors and in Vitro Cytotoxicity Studies
Durgesh Gurukkala Valapil, Geetanjali Devabattula, Aman Singh Barahdia, et al.
(2024)
Closed Access
Durgesh Gurukkala Valapil, Geetanjali Devabattula, Aman Singh Barahdia, et al.
(2024)
Closed Access
Design, synthesis, anti‐cancer, anti‐inflammatory and in silico studies of 3‐substituted‐2‐oxindole derivatives
Mahesh G. Hublikar, Vikas D. Kadu, Nagesh Edake, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 11
Closed Access
Mahesh G. Hublikar, Vikas D. Kadu, Nagesh Edake, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 11
Closed Access
Discovery of novel bioactive compounds in Catharanthus roseus exhibiting anti-angiogenic activity against VEGFR-2 TKD for Glioblastoma tumour growth suppression
Anna Senrung, Durgesh Kumar, Nidhi Bhardwaj, et al.
(2024) Vol. 11, Iss. 2
Open Access
Anna Senrung, Durgesh Kumar, Nidhi Bhardwaj, et al.
(2024) Vol. 11, Iss. 2
Open Access
